drugset / Trial / NCT00857168

To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion

NCT00857168

Phase 1 Completed 36 enrolled Acrux DDS Pty Ltd
RandomizedParallel-groupOpen-label

Summary

Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a propriety testosterone replacement product, Testosterone MD-Lotion and this study will evaluate the impact of application of antiperspirant and deodorant on absorption of testosterone, when applied pre-application of Testosterone MD-Lotion® (cutaneous solution). The study also aim to evaluate the impact of washing the application site on the absorption of testosterone, when washed post-application of Testosterone MD-Lotion® (cutaneous solution).

Timeline

Start
2009-01
Primary completion
2009-02
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 2 % Topical

Indications